Novo Nordisk ( NVO -1.22%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment. Never before was there a drug that actually worked for weight loss.

Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and ...

Ozempic is a brand name for semaglutide and is a prescription medication developed by leading Danish pharmaceutical company Novo Nordisk. It functions as a glucagon-like peptide-1 (GLP-1 ...

Now, semaglutide maker Novo Nordisk is chiming in ... “When it comes to fake, illegitimate Ozempic or Wegovy, consumers don’t know what’s in the vials—but whatever it is, it’s not ...

“Novo Nordisk is warning consumers about the significant dangers of reaching for illegitimate compounded ‘semaglutide’ drugs, which have been shown to contain impurities and ingredients ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...